Senior insider sale
President and CEO at ACRIVON THERAPEUTICS, INC. — senior position signals high conviction
$34.0K
15.75K shares
What this filing means
BLUME-JENSEN PETER plans to sell 15.75K shares of ACRIVON THERAPEUTICS, INC. valued at approximately $34.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/26/2026ACC: 0000905148-26-003924
DirectorOfficer· President and CEO
Since Mar 2026
15.75K
Shares to sell
$34.0K
Approx. market value
41.17K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Settlement of vested RSUs issued under an S-8 Registration Plan
Equity compensation for services rendered
8/21/2026
41.17KTotal acquired41.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/21/2026 | Settlement of vested RSUs issued under an S-8 Registration Plan Equity compensation for services rendered | 41.17K | — |
| Total | 41.17K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.23K
Market value
$2.5K
8/18/2026
—Completed
Units to sell
484.00
Market value
$972.84
8/18/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
14.04K
Market value
$30.6K
8/25/2026
Total
Units
15.75K
Value
$34.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/18/2026 | 1.23K | $2.5K | — | Completed |
8/18/2026 | 484.00 | $972.84 | — | Completed |
| Planned — Approximate Date | ||||
8/25/2026 | 14.04K | $30.6K | NASDAQ | Planned |
| Total | 15.75K | $34.0K | ||